A randomized control trial of stress management for caregivers of stem cell transplant patients: Effect on patient quality of life and caregiver distress
Mark L. Laudenslager(University of Colorado Anschutz Medical Campus), Peter A. McSweeney(Mesoblast (United States)), Kristin Kilbourn(University of Colorado Denver), Crystal Natvig(University of Colorado Anschutz Medical Campus), Benjamin W. Brewer(University of Colorado Anschutz Medical Campus), Teresa L. Simoneau(University of Colorado Anschutz Medical Campus), Jon Gutman(University of Colorado Anschutz Medical Campus), Susan K. Mikulich‐Gilbertson(University of Colorado Anschutz Medical Campus), Timothy S. Sannes(Harvard University)
Cited by 64
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k